Search research articles
Contact Us
Filters
Showing results (61-70 of 194) with videos related to
Page
of 20
Sort By:
Journal of Autoimmunity
|
April 1, 1992
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies
D Chabannes, B Ryffel, J F Borel
Experimental Nephrology
|
November 1, 1994
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin
B Ryffel, E Weber, M J Mihatsch
Kidney International. Supplement
|
December 1, 1995
The differential diagnosis between rejection and cyclosporine toxicity
M J Mihatsch, B Ryffel, F Gudat
Transplantation Proceedings
|
April 1, 1993
Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy
M J Mihatsch, B Ryffel, F Gudat
Toxicology Letters
|
December 1, 1992
Pathology induced by interleukin-6
B Ryffel, M Kammüller, R Robison, et al.
The American Journal of Pathology
|
July 1, 1991
Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha
B Ryffel, M Brockhaus, U Dürmüller, et al.
Clinical Immunology (Orlando, Fla.)
|
February 29, 2000
Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice
M Jacobs, N Brown, N Allie, et al.
Journal of Receptor Research
|
January 1, 1993
Evidence for shared receptor proteins for human interleukin-3 and granulocyte-macrophage colony-stimulating factor in the human M-07 cell line
G Woerly, G Zenke, U Strittmatter, et al.
Clinical Nephrology
|
January 1, 1986
Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy
B Ryffel, A M Müller, M J Mihatsch
Drug and Chemical Toxicology
|
January 1, 1992
Immunosuppression and cancer: the ciclosporin case
B Ryffel, M J Mihatsch, G L Fisher
Page
of 20
Search research articles
Search
Showing results (61-70 of 194) with videos related to
Sort By:
Page
of 20
Journal of Autoimmunity
|
April 1, 1992
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies
D Chabannes, B Ryffel, J F Borel
Experimental Nephrology
|
November 1, 1994
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin
B Ryffel, E Weber, M J Mihatsch
Kidney International. Supplement
|
December 1, 1995
The differential diagnosis between rejection and cyclosporine toxicity
M J Mihatsch, B Ryffel, F Gudat
Transplantation Proceedings
|
April 1, 1993
Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy
M J Mihatsch, B Ryffel, F Gudat
Toxicology Letters
|
December 1, 1992
Pathology induced by interleukin-6
B Ryffel, M Kammüller, R Robison, et al.
The American Journal of Pathology
|
July 1, 1991
Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha
B Ryffel, M Brockhaus, U Dürmüller, et al.
Clinical Immunology (Orlando, Fla.)
|
February 29, 2000
Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice
M Jacobs, N Brown, N Allie, et al.
Journal of Receptor Research
|
January 1, 1993
Evidence for shared receptor proteins for human interleukin-3 and granulocyte-macrophage colony-stimulating factor in the human M-07 cell line
G Woerly, G Zenke, U Strittmatter, et al.
Clinical Nephrology
|
January 1, 1986
Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy
B Ryffel, A M Müller, M J Mihatsch
Drug and Chemical Toxicology
|
January 1, 1992
Immunosuppression and cancer: the ciclosporin case
B Ryffel, M J Mihatsch, G L Fisher
Page
of 20